Single Point Partners’s Boston Scientific BSX Stock Holding History

Single Point Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-60,234	Closed	-$3.01M	–	85
2023 Q1	$3.01M	Buy	60,234 +17,512	+41%	+$825K	0.66%	27
2022 Q4	$1.98M	Sell	42,722 -115	-0.3%	-$4.98K	0.48%	31
2022 Q3	$1.66M	Buy	42,837 +22	+0.1%	+$883	0.46%	33
2022 Q2	$1.6M	Buy	+42,815	New	+$1.74M	0.44%	28

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Single Point Partners's BSX Position: Q2 2023 in Review

Single Point Partners sold out of Boston Scientific (BSX) in Q2 2023, closing a stake of 60,234 shares — an estimated $3.01M sold.

Single Point Partners first reported a position in BSX in Q2 2022 and held it in 4 quarters. The position peaked at $3.01M in Q1 2023. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

Single Point Partners reported no remaining Boston Scientific position as of Q2 2023 after selling out during the quarter.
Single Point Partners sold 60,234 Boston Scientific shares in Q2 2023, an estimated $3.01M.
Single Point Partners first reported a position in Boston Scientific in Q2 2022 and held it in 4 quarters.
Single Point Partners's Boston Scientific position peaked at $3.01M in Q1 2023.
1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Single Point Partners's 13F filing for Q2 2023, filed 10 Jul 2023.